Humacyte, Inc.
HUMA
Jodie situation report
Humacyte, Inc.'s move is being confirmed by its market group.
No new filing conclusion is available. 7 of 11 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 4 directly disclosed connections are confirming.
- At least 8 of 11 members remain active in the next snapshot.
- Capital-flow agreement rises above 55%.
- A filing-linked outsider such as BTGO begins moving with the group.
Invalidation: The live read weakens if participation falls to 3 of 11 members or fewer.
Who this business touches
The relationships behind HUMA
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
FMSFresenius Medical Care AGpartnerMay 13, 2026 ▾
“On April 21, 2026, we entered into the Third Amendment to our distribution agreement with Fresenius Medical Care.”
TMOThermo Fisher Scientific IncsupplierMar 27, 2026 ▾
“We source bioprocess solutions, including culture media and decellularization buffers, from a division of Thermo Fisher Scientific, which has a second production site to provide redundant media/buffer production capacity.”
FMSFresenius Medical Care AGdistributorMar 27, 2026 ▾
“Distribution Agreement with Fresenius Medical Care We entered into a distribution agreement with Fresenius Medical Care in June 2018 which, as amended as of February 16, 2021, granted Fresenius Medical Care and its affiliates exclusive rights to develop outsi…”
Filing peers
No filing peers are available for this name yet.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 1 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
HUMA is currently a Participant in the organic co-movement group Quantum Technology. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.